ABT Stock UPDATES Abbott Laboratories (ABT) 42.83 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abbott Laboratories (ABT) 42.83 $ABT

FTC sues AbbVie, Teva over generic AndroGel
AP - Mon Sep 08, 1:53PM CDT
NEW YORK (AP) — The Federal Trade Commission is suing drugmakers AbbVie and Teva, saying they conspired to temporarily keep generic versions of AbbVie's low-testosterone drug AndroGel off the market.

Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts
M2 - Mon Sep 08, 8:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wcgzf7/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2014: Supplier Shares and Country Forecasts" report to their offering. This new 318-page report from contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 2014 Strategies for the Global Drugs of Abuse Testing Market is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay. The report provides test volume and sales forecasts by country and market segment for the following assays: - Amphetamines - Antidepressants - Barbiturates - Benzodiazepines - Cannabinoids/Marijuana - Cocaine - LSD - Methadone - Methaqualone - Opiates - Phencyclidine (PCP) - Propoxphene Key Topics Covered: A. Major Drugs of Abuse B. Instrumentation Review C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Distribution Strategies for Decentralized Testing Markets E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Companies Mentioned - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/wc...e_horizons

New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs
PR Newswire - Mon Sep 08, 8:24AM CDT
A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately $2.2 million (EUR 1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly IlL (RADICAL) study, presented today at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, D.C.

Why Baxter International Offers Great Reward for Minimal Risk
at The Street - Mon Sep 08, 5:00AM CDT
Wall Street is wrong to discount Baxter's value-creating potential.

Australia Peripheral Vascular & Cardiovascular Procedures Devices Market Outlook to 2020 New Report Available at MarketOptimizer.org
PRWeb - Sun Sep 07, 8:30PM CDT
Australia Peripheral Vascular Devices Market Outlook to 2020

Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 3:35PM CDT
Abbott Labs (ABT) received positive news when its FreeStyle Libre Flash Glucose Monitoring System obtained CE Mark (Conformite Europeenne) in Europe.

Shares of ABT Up 9.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 05, 11:20AM CDT
SmarTrend identified an Uptrend for Abbott Laboratories (NYSE:ABT) on April 22nd, 2014 at $38.75. In approximately 5 months, Abbott Laboratories has returned 9.85% as of today's recent price of $42.56.

The Zacks Analyst Blog Highlights: Google, AbbVie, Abbott Laboratories, Apple and Intel
PR Newswire - Fri Sep 05, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Google (Nasdaq:GOOGL-Free Report), AbbVie (NYSE:ABBV-Free Report), Abbott Laboratories (NYSE:ABT-Free Report), Apple Inc. (Nasdaq:AAPL-Free Report) and Intel (Nasdaq:INTC-Free Report).

Global Mobile Health and Fitness Sensor Market 2014-2018: Increased Health Awareness Sees Market Set to Grow at a CAGR of 40%
M2 - Fri Sep 05, 8:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mfnjth/global_mobile) has announced the addition of the "Global Mobile Health and Fitness Sensor Market 2014-2018" report to their offering. The Global Mobile Health and Fitness Sensor market to grow at a CAGR of 40.29 percent over the period 2013-2018. A sensor measures physical quantity and converts raw data into observable data, which are used by various industries. Mobile health and fitness sensors are used in health and fitness devices to measure various body parameters. Rapid and continuous development in sensing technology can assist in regular patient monitoring. Going forward, the use of mobile health and fitness sensors in consumer healthcare is expected to boost the Global Mobile Health and Fitness Sensor market. The Global Mobile Health and Fitness Sensor market covers the present scenario and the growth prospects for the period 2014-2018. To calculate market size, the report takes into account the unit shipments of health and fitness sensors used in wearable, implantable, and mobile health and fitness devices. With growing demand from consumers, vendors have started developing multi-functional sensors that can be used to measure different body activities with a single device. The decreasing size of sensors led to a concomitant increase in the demand for implantable sensors. This demand is expected to increase during the forecast period of 2013-2018. According to the report, increased health awareness is a major driver for the Global Mobile Health and Fitness Sensor market. Aging populations and an increased incidence of diseases coupled with higher healthcare costs are some of the concerns and people are becoming increasingly health conscious and are constantly monitoring their body condition to keep fit. Further, the report states that lack of standardization among health and fitness devices remains a major challenge to the growth of the Global Mobile Health and Fitness Sensor market. Key Vendors - Abbott Laboratories - Acute Technology - Bayer HealthCare - F. Hoffmann-La Roche - Fujitsu - GE Healthcare - Honeywell International - LifeScan - Medtronic - OMRON - RF Technologies Other Prominent Vendors - Adidas - AgaMatrix - Analog Devices - Asahi Kasei Microdevices - Bosch Healthcare - Cardiocomm Solutions - Casio - Cellnovo - ChoiceMmed - Covidien - EM Microelectronic - Jawbone - Lifecomm - Philips - Qualcomm - ST Microelectronics - Texas Instruments - Zensorium Market Drivers/Challenges/Trends - Increased Health Awareness - Lack of Standardization - Rapid Growth in Combo Sensors Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by End-users - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/mf...bal_mobile

Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential
at The Street - Fri Sep 05, 5:00AM CDT
There's no compelling reason to buy this stock above $40.

Google's Calico in $500M Joint Venture with AbbVie - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 3:38PM CDT
Calico, Google's (GOOGL) year-old health startup is collaborating with biotechnology drugmaker, AbbVie, a spin-off from Abbott Laboratories (ABT), for a joint venture to formulate treatments for cancer and Alzheimer's.

Global Companion Diagnostic Technologies Market Opportunities and Forecasts 2013 - 2020
M2 - Thu Sep 04, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qr68q/global_companion) has announced the addition of the "Global Companion Diagnostic Technologies Market (Indication and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The global companion diagnostic market is expected to reach $3.5 billion by 2020, and it would grow at a CAGR of 20% from 2014 to 2020 Companion diagnostics market by indication is segmented into oncology, cardiovascular, CNS, autoimmune & inflammation, virology and others. Presently, majority of the companion diagnostics have been developed for cancer and thus, it is the major revenue generating segment in the overall CD indication market. Companion diagnostics have been developed for breast cancer, lung cancer, colorectal cancer, gastric cancer and melanomas. Companion diagnostics for breast cancer is the highest revenue generator mainly because there has been an increase in the incidences of breast cancer and many companion diagnostics have been developed for detection of the HER/neu biomarker for breast cancer. As of now, companion diagnostics for cardiovascular conditions, central nervous system conditions , inflammation and autoimmune diseases and viral diseases are very few, with a majority still in development stage; however, as more and more biomarkers are being discovered, there would be an increase in development of new companion diagnostics. Companion diagnostics market by technology is segmented into immmunohistochemistry and molecular diagnostics. Molecular diagnostics has been the most favored technology and it is expected that next generation sequencing and real-time PCR would drive the growth of this market owing to recent advancements in these technologies. KEY DELIVERABLES MARKET BY INDICATIONS - Oncology - Cardiovascular - Central Nervous System - Auto immune & Inflammation - Virology - Others MARKET BY TECHNOLOGY - Immunohistochemistry - Molecular diagnostics - In situ Hybridization - FISH - CISH - Real time PCR - Gene Sequencing COMPANY PROFILES - Abbott Laboratories - bioMerieux - Dako (Agilent Technologies) - Leica Microsystems - Life Technologies - Myriad Genetics - Qiagen - Resonance Health Ltd - Roche - Ventana Medical Systems For more information visit http://www.researchandmarkets.com/research/3q..._companion

RBCC Explores Novel Uses for New Naltrexone Delivery Protocols
Business Wire - Thu Sep 04, 4:00AM CDT
From chronic pain to obesity, new research suggests that there are practically no limits to the number of illnesses that the prescription drug Naltrexone can treat. Biotech company Rainbow Coral Corp. (OTCBB:RBCC) is working to make Naltrexone more effective than ever before.

Abbott Laboratories Rises 1.26% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Sep 03, 3:57PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $42.35 to a high of $42.79. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $42.60 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

FDA: Little evidence to support testosterone drugs
By MATTHEW PERRONE - AP - Wed Sep 03, 2:18PM CDT
WASHINGTON (AP) — The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious risks.

Google's health startup forges venture with AbbVie
AP - Wed Sep 03, 1:09PM CDT
SAN FRANCISCO (AP) — Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.

Global Heart Valve Repair and Replacement Market 2014-2018 - Key Vendors are Abbott Laboratories, Edward Lifesciences, Medtronic & St. Jude Medical
M2 - Wed Sep 03, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4bq7ck/global_heart) has announced the addition of the "Global Heart Valve Repair and Replacement Market 2014-2018" report to their offering. The Global Heart Valve Repair and Replacement market to grow at a CAGR of 7.72 percent over the period 2013-2018. Heart valves are structures in the human heart which control the flow of blood during the cardiac cycle. A person affected with heart valve diseases such as valvular stenosis, valvular insufficiency or regurgitation, prolapse, and atresia requires the repair or replacement of the natural heart valves. Aortic valves cannot be repaired; therefore, it is replaced using prosthetic heart valves. However, the mitral, tricuspid, and pulmonary valves can be repaired as well as replaced depending on the diseased condition and functionality of these valves. Heart valve repair and replacement devices are used for repairing the diseased heart valves as well as for replacing the natural valves with prosthetic valves. One of the emerging trends in the market is the increase in the number of products approved by regulatory authorities such as the FDA and CE. Such products are considered to be safe for commercial use increasing their adoption rate. According to the report, the increase in the aging population is one of the major drivers in the market. The incidence of cardiac disorders is more prevalent among the aging population across the world and people above the age of 60 years affected by heart valve diseases is expected to contribute to the growth the market. Further, the report states that the potential risk of complications associated with the use of heart valve repair and replacement devices is proving to be a barrier to the adoption of these devices. Some of the complications are device migration, infection, thrombosis, and mortality. In terms of application, the Global Heart Valve Repair and Replacement market can be segmented into two: - Heart Valve Repair - Heart Valve Replacement Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the Key Market Trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Key Vendors - Abbott Laboratories - Edward Lifesciences - Medtronic - St. Jude Medical Other Prominent Vendors - AorTech - Boston Scientific - Colibri Heart Valve - CryoLife - Direct Flow Medical - JenaValve - MiCardia - Mitralign - Neovasc - On-X Life Technologies - Sorin - Symentis - ValveXchange For more information visit http://www.researchandmarkets.com/research/4b...obal_heart

Abbott Receives CE Mark for FreeStyle® Libre, a Revolutionary Glucose Monitoring System for People with Diabetes
PR Newswire - Wed Sep 03, 8:30AM CDT
Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes. The system eliminates the need for routine finger pricks1, reading glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. In addition, no finger prick calibration is needed--a key differentiator from current continuous glucose monitoring systems. The system will be available in seven countries across Europe in the coming weeks.

Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott
PR Newswire - Wed Sep 03, 8:20AM CDT
Today, Analysts Review released its research reports regarding United Therapeutics Corporation (NASDAQ: UTHR), Illumina, Inc. (NASDAQ: ILMN), AstraZeneca plc (NYSE: AZN), Eli Lilly and Co. (NYSE: LLY) and Abbott Laboratories (NYSE: ABT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6174-100free.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 37

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 64

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 106

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 63

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 85

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 23

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 160

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 49

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 348

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Flow Beverage Welcomes José Bautista as Advisor and Announces Fundraising Progress

Updated Category News Views 336

Flow Beverage Corp. Welcomes José Bautista as Strategic Advisor Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) has recently made a significant move by bringing on board José Bautista as a Strategic Advisor. This addition is seen as a promising enhancement to the company's team, aligning with its dedication to excellence and innovation in the beverage sector. Background of...

Continue Reading
Milan Laser Hair Removal Marks a Significant 400 Clinic Milestone

Updated Category News Views 207

Milan Laser Hair Removal Reaches 400 Clinics Nationwide The leading provider in laser hair removal achieves a remarkable milestone with nationwide expansion efforts. Milan Laser Hair Removal, the hallmark of laser hair removal in the nation, proudly celebrates the grand opening of its 400th clinic, symbolizing a major advancement in its rapid expansion across the country....

Continue Reading
Global Vertical Roller Mill Market Expands to USD 1.04 Billion

Updated Category News Views 215

Understanding the Global Vertical Roller Mill Market The Vertical Roller Mill (VRM) market is anticipated to experience significant growth in the coming years. Currently valued at approximately USD 608.5 million in 2024, projections indicate that it will reach USD 1,041.2 million by 2033, achieving a compound annual growth rate (CAGR) of 6.1%. This increase is largely due...

Continue Reading
Pulsar Helium Provides Insights on Progress at Topaz Project

Updated Category News Views 313

Pulsar Helium Develops Well-Testing Strategy at Topaz Project Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF), a leading helium development company, has recently provided valuable updates regarding its well-testing activities at the Topaz project, located in Minnesota. This momentous phase in the project holistically aims to assess helium extraction capabilities...

Continue Reading
Trade Disclosures: Treatt plc's Key Operations Analyzed

Updated Category News Views 178

Understanding Recent Trade Disclosures by Treatt plc Treatt plc, a company known for its expertise in manufacturing and distributing essential oils and flavouring agents, operates in a competitive sector where trade disclosures play a crucial role in maintaining transparency and building investor trust. As we delve into the recent disclosures made by Treatt plc, we'll...

Continue Reading